Showing 11,841 - 11,860 results of 65,230 for search '(( 5 mm decrease ) OR ( 5 ((we decrease) OR (((nn decrease) OR (a decrease)))) ))', query time: 1.08s Refine Results
  1. 11841

    DataSheet1_Human SHQ1 variants R335C and A426V lead to severe ribosome biogenesis defects when expressed in yeast.PDF by Ismaël Alidou-D’Anjou (17037726)

    Published 2023
    “…To investigate the molecular defects caused by mutations R335C and A426V we used a conditional yeast strain that can be depleted of the endogenous Shq1 protein while constitutively expressing human SHQ1 (wild-type or variants). …”
  2. 11842

    The single cell data set of "Spatiotemporal Characterization of Single-Stranded DNA Intermediates after UV Irradiation: II. Effects of recA and recJ" by Remy Ripandelli (19572919)

    Published 2025
    “…In repair-proficient strains, UV exposure triggers an immediate rise in SSB-associated fluorescence, followed by a rapid decline in marker intensity between 10–45 minutes as gaps are repaired; gap counts decrease more gradually over roughly three hours. …”
  3. 11843
  4. 11844
  5. 11845
  6. 11846

    DataSheet_2_NLRC3 High Expression Represents a Novel Predictor for Positive Overall Survival Correlated With CCL5 and CXCL9 in HCC Patients.xlsx by Chengpan Wang (8790797)

    Published 2022
    “…NLRC3-knockdown Hepa1-6 tumors displayed decreased CD8<sup>+</sup> T cell infiltration. At the same time, we also found the positive correlations between NLRC3 and CCL5 (C-C motif chemokine ligand 5, P<0.0001, R<sup>2</sup> = 0.2372) as well as CXCL9 (C-X-C motif chemokine ligand 9, P<0.0001, R<sup>2</sup> = 0.2338) expressions. …”
  7. 11847

    DataSheet_3_NLRC3 High Expression Represents a Novel Predictor for Positive Overall Survival Correlated With CCL5 and CXCL9 in HCC Patients.xlsx by Chengpan Wang (8790797)

    Published 2022
    “…NLRC3-knockdown Hepa1-6 tumors displayed decreased CD8<sup>+</sup> T cell infiltration. At the same time, we also found the positive correlations between NLRC3 and CCL5 (C-C motif chemokine ligand 5, P<0.0001, R<sup>2</sup> = 0.2372) as well as CXCL9 (C-X-C motif chemokine ligand 9, P<0.0001, R<sup>2</sup> = 0.2338) expressions. …”
  8. 11848

    DataSheet_1_NLRC3 High Expression Represents a Novel Predictor for Positive Overall Survival Correlated With CCL5 and CXCL9 in HCC Patients.docx by Chengpan Wang (8790797)

    Published 2022
    “…NLRC3-knockdown Hepa1-6 tumors displayed decreased CD8<sup>+</sup> T cell infiltration. At the same time, we also found the positive correlations between NLRC3 and CCL5 (C-C motif chemokine ligand 5, P<0.0001, R<sup>2</sup> = 0.2372) as well as CXCL9 (C-X-C motif chemokine ligand 9, P<0.0001, R<sup>2</sup> = 0.2338) expressions. …”
  9. 11849
  10. 11850
  11. 11851

    Nickel Complexes Bearing ONS Chelating Ligands: A Promising Contender for In Vitro Cytotoxicity Effects on Human Pancreatic Cancer MIA-PaCa‑2 Cells by Deepika Tanwar (14329312)

    Published 2023
    “…Nickel complexes are recently gaining interest in anticancer activities on different types of cancer cells. Hence, in this study, we synthesized and characterized a series of ONS donor ligands [2-HO–C<sub>6</sub>H<sub>4</sub>–CHN–(C<sub>6</sub>H<sub>4</sub>)–SH] (<b>L1</b>), [2-OH-3-OMe–C<sub>6</sub>H<sub>3</sub>–CHN–(C<sub>6</sub>H<sub>4</sub>)–SH] (<b>L2</b>), [2-OH-3,5-(C(Me)<sub>3</sub>)<sub>2</sub>–C<sub>6</sub>H<sub>2</sub>–CHN–(C<sub>6</sub>H<sub>4</sub>)–SH] (<b>L3</b>), [2-OH–C<sub>6</sub>H<sub>4</sub>–CHN–(C<sub>6</sub>H<sub>4</sub>)–SMe] (<b>L4</b>), [2-OH-3-OMe–C<sub>6</sub>H<sub>3</sub>–CHN–(C<sub>6</sub>H<sub>4</sub>)–SMe] (<b>L5</b>), [2-OH-3,5-(C(Me)<sub>3</sub>)<sub>2</sub>–C<sub>6</sub>H<sub>2</sub>–CHN–(C<sub>6</sub>H<sub>4</sub>)–SMe] (<b>L6</b>) and their Ni(II) metal complexes [(MeOH)Ni(<b>L1–L1–</b>4H)] (<b>1</b>), [(MeOH)Ni(<b>L2–L2–</b>4H)] (<b>2</b>), [(MeOH)Ni(<b>L3–L3–</b>4H)] (<b>3</b>), [(<b>L4–</b>H)<sub>2</sub>Ni] (<b>4</b>), [(<b>L5–</b>H)<sub>2</sub>Ni] (<b>5</b>), and [(<b>L6–</b>H)<sub>2</sub>Ni] (<b>6</b>). …”
  12. 11852

    Table_2_Cerebral Small Vessel Disease Load Predicts Functional Outcome and Stroke Recurrence After Intracerebral Hemorrhage: A Median Follow-Up of 5 Years.DOCX by Mangmang Xu (10165901)

    Published 2021
    “…Death occurred in 36.1% (13/36) of patients with CMBs ≥ 10 compared with 18.8% (22/117) in those with CMB < 10 (adjusted HR 2.669, 95% CI 1.248–5.707, p = 0.011). In addition, the cumulative CSVD score ≥ 2 was associated with a decreased survival rate (adjusted HR 3.140, 95% CI 1.066–9.250, p = 0.038).…”
  13. 11853

    Presentation_1_A Novel Multifunctional 5,6-Dimethoxy-Indanone-Chalcone-Carbamate Hybrids Alleviates Cognitive Decline in Alzheimer’s Disease by Dual Inhibition of Acetylcholinester... by Chan Liu (5545364)

    Published 2022
    “…</p>Conclusion<p>Together, our work demonstrated that AP5 inhibited the AChE activity, decreased Aβ plaque deposition by interfering Aβ aggregation and promoting microglial Aβ phagocytosis, and suppressed inflammation, thereby rescuing neuronal and synaptic damage and relieving cognitive decline. …”
  14. 11854

    Table_1_Cerebral Small Vessel Disease Load Predicts Functional Outcome and Stroke Recurrence After Intracerebral Hemorrhage: A Median Follow-Up of 5 Years.DOCX by Mangmang Xu (10165901)

    Published 2021
    “…Death occurred in 36.1% (13/36) of patients with CMBs ≥ 10 compared with 18.8% (22/117) in those with CMB < 10 (adjusted HR 2.669, 95% CI 1.248–5.707, p = 0.011). In addition, the cumulative CSVD score ≥ 2 was associated with a decreased survival rate (adjusted HR 3.140, 95% CI 1.066–9.250, p = 0.038).…”
  15. 11855

    Presentation_1_A Novel Multifunctional 5,6-Dimethoxy-Indanone-Chalcone-Carbamate Hybrids Alleviates Cognitive Decline in Alzheimer’s Disease by Dual Inhibition of Acetylcholinester... by Chan Liu (5545364)

    Published 2022
    “…</p>Conclusion<p>Together, our work demonstrated that AP5 inhibited the AChE activity, decreased Aβ plaque deposition by interfering Aβ aggregation and promoting microglial Aβ phagocytosis, and suppressed inflammation, thereby rescuing neuronal and synaptic damage and relieving cognitive decline. …”
  16. 11856

    Table_3_Cerebral Small Vessel Disease Load Predicts Functional Outcome and Stroke Recurrence After Intracerebral Hemorrhage: A Median Follow-Up of 5 Years.docx by Mangmang Xu (10165901)

    Published 2021
    “…Death occurred in 36.1% (13/36) of patients with CMBs ≥ 10 compared with 18.8% (22/117) in those with CMB < 10 (adjusted HR 2.669, 95% CI 1.248–5.707, p = 0.011). In addition, the cumulative CSVD score ≥ 2 was associated with a decreased survival rate (adjusted HR 3.140, 95% CI 1.066–9.250, p = 0.038).…”
  17. 11857

    Table_4_Cerebral Small Vessel Disease Load Predicts Functional Outcome and Stroke Recurrence After Intracerebral Hemorrhage: A Median Follow-Up of 5 Years.DOCX by Mangmang Xu (10165901)

    Published 2021
    “…Death occurred in 36.1% (13/36) of patients with CMBs ≥ 10 compared with 18.8% (22/117) in those with CMB < 10 (adjusted HR 2.669, 95% CI 1.248–5.707, p = 0.011). In addition, the cumulative CSVD score ≥ 2 was associated with a decreased survival rate (adjusted HR 3.140, 95% CI 1.066–9.250, p = 0.038).…”
  18. 11858
  19. 11859
  20. 11860